Literature DB >> 8611877

Crossover study of glyceryl trinitrate patches for controlling pain in women with severe dysmenorrhoea.

R Pittrof1, C Lees, C Thompson, A Pickles, J F Martin, S Campbell.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8611877      PMCID: PMC2350607          DOI: 10.1136/bmj.312.7035.884

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  5 in total

Review 1.  Dysmenorrhea.

Authors:  M Y Dawood
Journal:  Clin Obstet Gynecol       Date:  1990-03       Impact factor: 2.190

2.  A comparative study of the effect of high-intensity transcutaneous nerve stimulation and oral naproxen on intrauterine pressure and menstrual pain in patients with primary dysmenorrhea.

Authors:  I Milsom; N Hedner; C Mannheimer
Journal:  Am J Obstet Gynecol       Date:  1994-01       Impact factor: 8.661

3.  Arrest of preterm labour and prolongation of gestation with glyceryl trinitrate, a nitric oxide donor.

Authors:  C Lees; S Campbell; E Jauniaux; R Brown; B Ramsay; D Gibb; S Moncada; J F Martin
Journal:  Lancet       Date:  1994-05-28       Impact factor: 79.321

4.  Analysis of uterine contractility after administration of the non-steroidal anti-inflammatory drug nimesulide.

Authors:  M Pulkkinen; T Monti; A Macciocchi
Journal:  Acta Obstet Gynecol Scand       Date:  1992-04       Impact factor: 3.636

5.  Dose dependent pharmacokinetics of nitroglycerin after multiple intravenous infusions in healthy volunteers.

Authors:  P K Noonan; R L Williams; L Z Benet
Journal:  J Pharmacokinet Biopharm       Date:  1985-04
  5 in total
  2 in total

1.  Transdermal glyceryl trinitrate for dysmenorrhoea. Confidence intervals for glyceryl trinitrate do not suggest a significant effect.

Authors:  A Li Wan Po; R W Stones
Journal:  BMJ       Date:  1996-08-10

2.  Peripheral and central activation of nitric oxide-cyclic GMP pathway by sildenafil.

Authors:  Chandrashekhar S Patil; Vijay Pal Singh; Shrinivas K Kulkarni
Journal:  Inflammopharmacology       Date:  2005       Impact factor: 4.473

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.